These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 36063141)

  • 1. Phenytoin to expedite sirolimus and tacrolimus elimination.
    Lemke AI; Boilson BA; Razonable RR; Bernard SA
    Clin Transplant; 2022 Dec; 36(12):e14809. PubMed ID: 36063141
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-tacrolimus combination for combined kidney-pancreas transplantation: effect on renal function.
    Salazar A; McAlister VC; Kiberd BA; Bitter-Suermann H; Al-Kerithy MF; MacDonald AS
    Transplant Proc; 2001; 33(1-2):1038-9. PubMed ID: 11267181
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients.
    Toso C; Morel P; Bucher P; Mathe Z; Demuylder-Mischler S; Bosco D; Berney T; Oberholzer J; Shapiro J; Oberholzer J; Philippe J
    Transplantation; 2003 Oct; 76(7):1133-4. PubMed ID: 14557767
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens.
    Gaston RS
    Transplant Proc; 1999 Dec; 31(8A):17S-22S. PubMed ID: 10616556
    [No Abstract]   [Full Text] [Related]  

  • 5. Medium-term outcome using sirolimus-tacrolimus combination in adult renal transplant recipients.
    Rashid I; El-Sabrout R; Butt F; Delaney V; Qadir M; Hanson P; Butt K
    Transplant Proc; 2002 Aug; 34(5):1649-50. PubMed ID: 12176520
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.
    Shapiro R; Scantlebury VP; Jordan ML; Vivas CA; Jain A; Hakala TR; McCauley J; Johnston J; Randhawa P; Fedorek S; Gray E; Chesky A; Dvorchik I; Donaldson J; Fung JJ; Starzl TE
    Transplant Proc; 2002 Aug; 34(5):1651-2. PubMed ID: 12176521
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange.
    Yango A; Morrissey P; Monaco A; Butera J; Gohh RY
    Clin Nephrol; 2002 Jul; 58(1):77-8. PubMed ID: 12141412
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplant histology after one year of continuous therapy with sirolimus compared with tacrolimus.
    Dean PG; Grande JP; Sethi S; Park WD; Griffin MD; Cosio FG; Larson TS; Stegall MD
    Transplantation; 2008 Apr; 85(8):1212-5. PubMed ID: 18431244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoregulatory effects of sirolimus vs. tacrolimus treatment in kidney allograft recipients.
    Gong N; Chen Z; Wang J; Fang A; Li Y; Xiang Y; Ming C; Zhang W
    Cell Immunol; 2015 Oct; 297(2):87-93. PubMed ID: 26205091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring adherence to medications: are complex methods superior to simple ones?
    Shemesh E
    Pediatr Transplant; 2012 Jun; 16(4):315-7. PubMed ID: 22452614
    [No Abstract]   [Full Text] [Related]  

  • 12. Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients.
    El-Sabrout R; Weiss R; Butt F; Delaney V; Qadir M; Hanson P; Butt K
    Transplant Proc; 2002 Aug; 34(5):1942-3. PubMed ID: 12176636
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation.
    Vilalta R; Vila A; Nieto J; Callís L
    Transplant Proc; 2003 Mar; 35(2):703-4. PubMed ID: 12644102
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal.
    Heilman RL; Younan K; Wadei HM; Mai ML; Reddy KS; Chakkera HA; Gonwa TA
    Transplantation; 2011 Oct; 92(7):767-73. PubMed ID: 21775930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
    Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
    Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
    [No Abstract]   [Full Text] [Related]  

  • 16. Sirolimus in combination with tacrolimus or mycophenolate mofetil for minimizing acute rejection risk in renal transplant recipients--a single center experience.
    El-Sabrout R; Delaney V; Qadir M; Butt F; Hanson P; Butt KM
    Transplant Proc; 2003 May; 35(3 Suppl):89S-94S. PubMed ID: 12742474
    [No Abstract]   [Full Text] [Related]  

  • 17. Experience with sirolimus for calcineurin minimization/elimination in pancreas-after-kidney transplantation.
    Gautam A; Morrissey PE; Gohh R; Yango A; Monaco AP
    Transplant Proc; 2005 Oct; 37(8):3542-3. PubMed ID: 16298654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of early conversion from tacrolimus to sirolimus on chronic allograft changes in kidney recipients on rapid steroid withdrawal.
    Heilman RL; Cortese C; Geiger XJ; Younan K; Wadei HM; Mai ML; Reddy KS; Gonwa TA
    Transplantation; 2012 Jan; 93(1):47-53. PubMed ID: 22067270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus: a new option in transplantation.
    Mota A
    Expert Opin Pharmacother; 2005 Mar; 6(3):479-87. PubMed ID: 15794738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.